Study of ATI-450 vs Placebo in Patients With Moderate to Severe Psoriatic Arthritis
Clinical trial NCT05511519 · TERMINATED
Trial details
- NCT number
- NCT05511519
- Sponsor
- Aclaris Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-12
- Primary completion
- 2023-12-06
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.